1475-2867

Cancer Cell International

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 2848 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact2848 DOIs
2

Add abstracts to 2076 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact2076 DOIs
3

Add license metadata to 821 records

License metadata tells indexers and readers how each article may be reused.

Low impact821 DOIs

DOIs for this ISSN

Showing the top 5 of 4827 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 — (10.1186/1475-2867-5-30)
Abstract References ORCID License
259.44 392
2 Clinical implications and utility of field cancerization (10.1186/1475-2867-7-2)
Abstract References ORCID License
235.98 228
3 Acidic extracellular microenvironment and cancer (10.1186/1475-2867-13-89)
Abstract ORCID License
229.44 1145
4 Wnt signal transduction pathway and apoptosis: a review (10.1186/1475-2867-10-22)
Abstract References ORCID License
212.39 132
5 — (10.1186/1475-2867-6-25)
Abstract References ORCID License
207.19 117
6 Resistance to cancer chemotherapy: failure in drug response… (10.1186/s12935-015-0221-1)
Abstract ORCID License
205.70 552
7 Metformin impairs growth of endometrial cancer cells via cel… (10.1186/1475-2867-14-53)
Abstract References ORCID License
202.12 104
8 Role of stem cells in cancer therapy and cancer stem cells:… (10.1186/1475-2867-7-9)
Abstract References ORCID License
200.43 100
9 From 'omics' to complex disease: a systems biology approach… (10.1186/1475-2867-10-11)
Abstract References ORCID License
199.12 97
10 Survivin: a unique target for tumor therapy (10.1186/s12935-016-0326-1)
Abstract ORCID License
193.57 380
11 Identification and validation of genes involved in gastric t… (10.1186/1475-2867-10-45)
Abstract References ORCID License
192.43 83
12 — (10.1186/1475-2867-5-4)
Abstract References ORCID License
191.91 82
13 Acetoacetate reduces growth and ATP concentration in cancer… (10.1186/1475-2867-9-14)
Abstract References ORCID License
190.85 80
14 Cyclooxygenase-2 promotes tumor growth and suppresses tumor… (10.1186/s12935-015-0260-7)
Abstract ORCID License
189.38 334
15 — (10.1186/1475-2867-5-34)
Abstract References ORCID License
188.65 76
16 Increasingly transformed MCF-10A cells have a progressively… (10.1186/1475-2867-9-7)
Abstract References ORCID License
186.33 72
17 Tumor suppressor gene E-cadherin and its role in normal and… (10.1186/1475-2867-3-17)
Abstract ORCID License
184.57 288
18 Combined xanthorrhizol-curcumin exhibits synergistic growth… (10.1186/1475-2867-9-1)
Abstract References ORCID License
179.24 61
19 — (10.1186/1475-2867-5-1)
Abstract References ORCID License
178.53 60
20 — (10.1186/1475-2867-6-11)
Abstract References ORCID License
178.53 60
21 — (10.1186/1475-2867-5-8)
Abstract References ORCID License
177.09 58
22 Translesion DNA synthesis in the context of cancer research (10.1186/1475-2867-11-39)
Abstract References ORCID License
174.04 54
23 — (10.1186/1475-2867-5-19)
Abstract References ORCID License
171.60 51
24 — (10.1186/1475-2867-5-21)
Abstract References ORCID License
171.60 51
25 Cathepsin L increases invasion and migration of B16 melanoma (10.1186/1475-2867-7-8)
Abstract References ORCID License
169.02 48
26 PADI4 and tumourigenesis (10.1186/1475-2867-10-7)
Abstract References ORCID License
168.12 47
27 Prostate specific membrane antigen (PSMA) expression in prim… (10.1186/1475-2867-14-26)
Abstract ORCID License
167.66 171
28 Differences in the epigenetic regulation of MT-3 gene expres… (10.1186/1475-2867-11-2)
Abstract References ORCID License
167.21 46
29 The role of cancer-associated fibroblasts, solid stress and… (10.1186/1475-2867-14-41)
Abstract ORCID License
167.09 168
30 Induction of G1-phase cell cycle arrest and apoptosis pathwa… (10.1186/s12935-016-0315-4)
Abstract ORCID License
166.51 165
31 Soluble L1CAM promotes breast cancer cell adhesion and migra… (10.1186/1475-2867-10-34)
Abstract References ORCID License
166.28 45
32 Base excision repair of ionizing radiation-induced DNA damag… (10.1186/1475-2867-7-15)
Abstract References ORCID License
165.32 44
33 Eurycomanone induce apoptosis in HepG2 cells via up-regulati… (10.1186/1475-2867-9-16)
Abstract References ORCID License
165.32 44
34 Combination of tunicamycin with anticancer drugs synergistic… (10.1186/1475-2867-7-5)
Abstract References ORCID License
163.35 42
35 Three steps to the immortality of cancer cells: senescence,… (10.1186/1475-2867-13-92)
Abstract ORCID License
162.55 146
36 Down-regulation of sfrp1 in a mammary epithelial cell line p… (10.1186/1475-2867-9-11)
Abstract References ORCID License
162.32 41
37 — (10.1186/1475-2867-4-6)
Abstract References ORCID License
161.28 40
38 Epigenetic regulator MLL2 shows altered expression in cancer… (10.1186/1475-2867-10-13)
Abstract References ORCID License
160.21 39
39 A structural approach to the role of CCN (CYR61/CTGF/NOV) pr… (10.1186/1475-2867-3-15)
Abstract ORCID License
159.53 133
40 — (10.1186/1475-2867-5-11)
Abstract References ORCID License
159.11 38
41 Effect of lycopene on cell viability and cell cycle progress… (10.1186/1475-2867-12-36)
Abstract ORCID License
156.21 120
42 C-Phycocyanin exerts anti-cancer effects via the MAPK signal… (10.1186/s12935-018-0511-5)
Abstract ORCID License
155.94 119
43 INTS6/DICE1 inhibits growth of human androgen-independent pr… (10.1186/1475-2867-9-28)
Abstract References ORCID License
155.63 35
44 Mitotic death: a mechanism of survival? A review (10.1186/1475-2867-1-1)
Abstract ORCID License
154.27 113
45 — (10.1186/1475-2867-4-5)
Abstract References ORCID License
153.15 33
46 — (10.1186/1475-2867-6-17)
Abstract References ORCID License
153.15 33
47 Targeting colorectal cancer stem cells using curcumin and cu… (10.1186/s12935-015-0241-x)
Abstract ORCID License
152.51 107
48 Role of the Hypoxia-inducible factor-1 alpha induced autopha… (10.1186/1475-2867-13-119)
Abstract ORCID License
152.20 106
49 Inhibition of androgen-independent prostate cancer cell grow… (10.1186/1475-2867-8-3)
Abstract References ORCID License
151.85 32
50 Therapeutic implications of osteoprotegerin (10.1186/1475-2867-9-26)
Abstract References ORCID License
151.85 32